coumarin has been researched along with Thrombopenia in 13 studies
2H-chromen-2-one: coumarin derivative
| Excerpt | Relevance | Reference |
|---|---|---|
| "A severe thrombotic thrombocytopenic status, induced by heparin in a sixty-nine-year-old woman undergoing total hip joint arthroplasty, was treated by switching the anticoagulant therapy to coumarin, which induced skin necrosis." | 7.69 | Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. ( Boda, Z; Pósán, E; Rigó, J; Shahak, A; Szücs, G, 1996) |
| "A patient with evidence of both heparin-related thrombocytopenia and coumarin-induced skin necrosis is presented." | 7.67 | Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report. ( Banson, B; Berman, JA; Celoria, GM; Friedmann, P; Rhee, SW; Steingart, RH, 1988) |
| "Significant advances in the pharmacological prophylaxis of venous thromboembolism have occurred since warfarin and unfractionated heparin were introduced for this indication nearly 60 years ago." | 4.82 | Current options in the prevention of thromboembolic disease. ( Ansell, J; Bergqvist, D, 2004) |
| " Introduction of coumarin therapy for venous thromboembolism should be started on day 1 of diagnosis, keeping the total duration of heparin therapy at no more than five days and therefore minimizing the incidence of heparin-induced thrombocytopenia." | 3.72 | [Anticoagulation in patients with venous thromboembolism]. ( Rüfer, A; Wuillemin, WA, 2003) |
| "A severe thrombotic thrombocytopenic status, induced by heparin in a sixty-nine-year-old woman undergoing total hip joint arthroplasty, was treated by switching the anticoagulant therapy to coumarin, which induced skin necrosis." | 3.69 | Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. ( Boda, Z; Pósán, E; Rigó, J; Shahak, A; Szücs, G, 1996) |
| "A patient with evidence of both heparin-related thrombocytopenia and coumarin-induced skin necrosis is presented." | 3.67 | Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report. ( Banson, B; Berman, JA; Celoria, GM; Friedmann, P; Rhee, SW; Steingart, RH, 1988) |
| " Because of their completely different chemical structure, hirudins are a safe alternative for anticoagulation." | 2.46 | The complex clinical picture of side effects to anticoagulation. ( Seitz, CS; Trautmann, A, 2010) |
| " Post-marketing experience suggests that standard dosing of lepirudin is too high; current recommendations are to avoid the initial lepirudin bolus and to begin with lower infusion rates, even in patients without overt renal dysfunction." | 2.43 | Think of HIT. ( Warkentin, TE, 2006) |
| " The guidelines include specific recommendations for nonheparin anticoagulant dosing that differ from the package inserts." | 1.35 | Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). ( Greinacher, A; Koster, A; Lincoff, AM; Warkentin, TE, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warkentin, TE | 5 |
| Greinacher, A | 2 |
| Koster, A | 1 |
| Lincoff, AM | 1 |
| Trautmann, A | 1 |
| Seitz, CS | 1 |
| Olah, Z | 1 |
| Bereczky, Z | 1 |
| Szarvas, M | 1 |
| Boda, Z | 2 |
| Rüfer, A | 1 |
| Wuillemin, WA | 1 |
| MOREO, GC | 1 |
| GIBELLI, A | 1 |
| Ansell, J | 1 |
| Bergqvist, D | 1 |
| Lubenow, N | 1 |
| Wessel, A | 1 |
| Sloane, DA | 1 |
| Krahn, EL | 1 |
| Magnani, HN | 1 |
| Shahak, A | 1 |
| Pósán, E | 1 |
| Szücs, G | 1 |
| Rigó, J | 1 |
| Levine, MN | 1 |
| Anderson, DR | 1 |
| Celoria, GM | 1 |
| Steingart, RH | 1 |
| Banson, B | 1 |
| Friedmann, P | 1 |
| Rhee, SW | 1 |
| Berman, JA | 1 |
5 reviews available for coumarin and Thrombopenia
| Article | Year |
|---|---|
The complex clinical picture of side effects to anticoagulation.
Topics: Anaphylaxis; Anticoagulants; Coumarins; Drug Eruptions; Fibrinolytic Agents; Fondaparinux; Heparin; | 2010 |
An overview of the heparin-induced thrombocytopenia syndrome.
Topics: Antibodies; Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Heparitin Sulfate; Humans; | 2004 |
Current options in the prevention of thromboembolic disease.
Topics: Administration, Oral; Anticoagulants; Coumarins; Fondaparinux; Heparin; Humans; Injections, Subcutan | 2004 |
Think of HIT.
Topics: Contraindications; Coumarins; Heparin; Humans; Practice Guidelines as Topic; Thrombin; Thrombocytope | 2006 |
Side-effects of antithrombotic therapy.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivi | 1990 |
1 trial available for coumarin and Thrombopenia
| Article | Year |
|---|---|
Side-effects of antithrombotic therapy.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivi | 1990 |
8 other studies available for coumarin and Thrombopenia
| Article | Year |
|---|---|
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Coumarins; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Count; Thrombocyt | 2008 |
Coagulation: cascade!
Topics: Aged; Anticoagulants; Coumarins; Enoxaparin; Gangrene; Heparin; Humans; International Normalized Rat | 2011 |
[Anticoagulation in patients with venous thromboembolism].
Topics: Anticoagulants; Bandages; Clinical Trials as Topic; Coumarins; Fibrinolytic Agents; Heparin; Heparin | 2003 |
[CAPILLARY-PROTECTIVE ACTION OF 4-METHYL-6,7-(BIS-BETA-DIETHYLAMINOETHOXY)-COUMARIN HYROCHLORIDE IN PARENTERAL AND ORAL ADMINISTRATION. STUDY OF BLEEDING TIME AND INTENSITY AND PETECHIOMETRY].
Topics: Administration, Oral; Bleeding Time; Capillaries; Coumarins; Hepatitis; Humans; Pharmacology; Purpur | 1963 |
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
Topics: Aged; Ancrod; Canada; Chondroitin Sulfates; Cohort Studies; Coumarins; Dermatan Sulfate; Female; Ger | 2006 |
Should vitamin K be administered when HIT is diagnosed after administration of coumarin?
Topics: Aged, 80 and over; Anticoagulants; Cardiac Surgical Procedures; Coumarins; Extremities; Gangrene; He | 2006 |
Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report.
Topics: Aged; Anticoagulants; Coumarins; Female; Heparin; Hip Prosthesis; Humans; Necrosis; Postoperative Co | 1996 |
Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report.
Topics: Aorta; Aorta, Thoracic; Coumarins; Female; Femoral Artery; Heparin; Humans; Intermittent Claudicatio | 1988 |